Thus, MCU was overrepresented in more aggressive and metastatic breast cancers, and downregulation of MCU in metastatic cell lines resulted in impaired growth, migration, and invasion in vitro, and metastasis and lymph node infiltration in vivo. This evidence concerns the gene MCU and breast cancer.